Literature DB >> 11731909

Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro.

H Nagase1, K Ikeda, Y Sakai.   

Abstract

We investigated the inhibitory effect of Magnolia obovata Thunb. bark ethanol extracts on human fibrosarcoma HT-1080 cells invasion in a reconstituted basement membrane [Matrigel (MG)]. We found that the effective components of the bark ethanol extracts were magnolol and honokiol, two biphenyl compounds. The extracts, magnolol and honokiol, did not affect HT-1080 cells adhesion to MG, but did inhibit HT-1080 cells migration at a high concentration (100 microM). HT-1080 cells secrete matrix metalloproteinase (MMP)-9, which degrades the extracellular matrix as a part of the invasive process. Magnolol and honokiol inhibited the activity of MMP-9, which may have been responsible, in part, for the inhibition of tumor cell invasiveness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731909     DOI: 10.1055/s-2001-18345

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  14 in total

1.  In vitro growth inhibition of human cancer cells by novel honokiol analogs.

Authors:  Jyh Ming Lin; A S Prakasha Gowda; Arun K Sharma; Shantu Amin
Journal:  Bioorg Med Chem       Date:  2012-04-03       Impact factor: 3.641

2.  Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.

Authors:  Dimiter B Avtanski; Arumugam Nagalingam; Michael Y Bonner; Jack L Arbiser; Neeraj K Saxena; Dipali Sharma
Journal:  Mol Oncol       Date:  2014-01-15       Impact factor: 6.603

3.  Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.

Authors:  Rebecca J Leeman-Neill; Quan Cai; Sonali C Joyce; Sufi M Thomas; Neil E Bhola; Daniel B Neill; Jack L Arbiser; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2010-04-13       Impact factor: 12.531

4.  Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage.

Authors:  Adilson Costa; Gustavo Facchini; Ana Lúcia T A Pinheiro; Michelle S da Silva; Michael Y Bonner; Jack Arbiser; Samara Eberlin
Journal:  Int J Dermatol       Date:  2017-02-22       Impact factor: 2.736

5.  Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.

Authors:  Fei Chen; Tao Wang; Yi-Feng Wu; Ying Gu; Xiao-Li Xu; Shu Zheng; Xun Hu
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

6.  Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO.

Authors:  Tao Wang; Fei Chen; Zhe Chen; Yi-Feng Wu; Xiao-Li Xu; Shu Zheng; Xun Hu
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 7.  Honokiol: a novel natural agent for cancer prevention and therapy.

Authors:  S Arora; S Singh; G A Piazza; C M Contreras; J Panyam; A P Singh
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

8.  Population structure and genetic diversity distribution in wild and cultivated populations of the traditional Chinese medicinal plant Magnolia officinalis subsp. biloba (Magnoliaceae).

Authors:  Jingsheng He; Ling Chen; Ying Si; Bo Huang; Xiaoquan Ban; Youwei Wang
Journal:  Genetica       Date:  2008-05-26       Impact factor: 1.082

9.  Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells.

Authors:  Shu-Er Yang; Ming-Tsuen Hsieh; Tung-Hu Tsai; Shih-Lan Hsu
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

10.  Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/Akt signaling pathways.

Authors:  Azhar Rasul; Bo Yu; Muhammad Khan; Kun Zhang; Furhan Iqbal; Tonghui Ma; Hong Yang
Journal:  Int J Oncol       Date:  2011-11-30       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.